Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
The firm's platform combines single-cell microbiology and machine learning to deliver a result in four to six hours.
Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells
The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test.
Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
The Ireland-based firm said its inexpensive capacitance-based assays deliver "molecular detection by proxy," providing rapid, multiplex, quantitative results.
Fluxergy Acquires InnaMed's Blood Testing Tech to Support Metabolic Panel Development
Fluxergy said adding the electrochemical biosensor technology will expand the capabilities of its decentralized sample-to-answer platform.
Dec 16, 2022
Nov 18, 2022
Jun 17, 2022
Jun 3, 2022
May 20, 2021
Mar 31, 2021
Dec 14, 2020